Concepedia

Tanya Siddiqi

TS

145

Publications

20.6K

Citations

52

H-Index

2008

Active since

Affiliations

City Of Hope National Medical Center(Current)

The University of Texas MD Anderson Cancer Center

Dana-Farber Cancer Institute

City of Hope

Massachusetts General Hospital

Tanya Siddiqi is an author at City Of Hope National Medical Center specializing in medicine, oncology, and cancer research.

ORCID

Top concepts

Publications per year

2008–2025

145

Publications

145

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

Sattva S. Neelapu, Frederick L. Locke, Nancy L. Bartlett et al. · New England Journal of Medicine · 2017 · 5.7K citations · Full text

Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study

Jeremy S. Abramson, M. Lia Palomba, Leo I. Gordon et al. · The Lancet · 2020 · 2.2K citations

, , +5

Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial

Frederick L. Locke, Armin Ghobadi, Caron A. Jacobson et al. · The Lancet Oncology · 2018 · 2.2K citations

, , +9

Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia

Jan A. Burger, Alessandra Tedeschi, Paul M. Barr et al. · New England Journal of Medicine · 2015 · 1.5K citations · Full text

Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma

Frederick L. Locke, Sattva S. Neelapu, Nancy L. Bartlett et al. · Molecular Therapy · 2017 · 601 citations · Full text

Rows per page

1–5 of 145